The effectiveness of amantadine and dalfampridine in improving fatigue in patients with multiple sclerosis: A randomized, double-blind, clinical trial

Background: Fatigue is a common complication associated with multiple sclerosis (MS). The aim of this study was to evaluate the impact of dalfampridine and amantadine on fatigue in patients with MS. Methods: This was a randomized, double-blind, clinical trial on patients with MS. The recruited patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeqi, Yasaman, Baghbanian, Seyed Mohammad, Bazi, Aliyeh, Ghazaeian, Monireh, Fallah, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189202/
https://www.ncbi.nlm.nih.gov/pubmed/38011342
http://dx.doi.org/10.18502/cjn.v21i4.11717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189202/
https://www.ncbi.nlm.nih.gov/pubmed/38011342
http://dx.doi.org/10.18502/cjn.v21i4.11717

Ejemplares similares